Towards Healthcare
Clinical Trial Software Market to Grow at 13.74% CAGR till 2034

Clinical Trial Software Market Boosted by Decentralized Trials

Based on market forecasts, the global clinical trial software market, projected at USD 0.9 billion in 2024, is expected to reach USD 3.23 billion by 2034, growing at a CAGR of 13.74% over the forecast period. The market is growing due to rising demand for digital tools that streamline trial design, data management, and regulatory compliance. Additionally, the surge in decentralized and virtual trials is accelerating the adoption of software solutions.

Content

  • Insight Code: 6132
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The clinical trial software market is worth USD 1.03 billion in 2025, and by 2034, it is forecasted to hit USD 3.23 billion, registering a CAGR of 13.74% over the decade.

North America is currently leading the clinical trial software market due to the region hosting a high concentration of contract research organizations (CROs) and technology-driven life sciences firms.

The clinical trial software market includes 5 segments by product/solution type, by deployment model, by end-user/buyer type, by therapeutic area, and by region.

Some key players include Medable, Signant Health, Clario, OmniComm Systems, Castor EDC, and Medrio.  

Software automates record-keeping, audit trails, and data validation, helping organizations adhere to FDA, EMA, HIPAA, and GDPR standards.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions